P&G Crest Whitestrips Patents Repel ‘Indefiniteness’ Challenge
This article was originally published in The Tan Sheet
Executive Summary
P&G prevails in U.S. district court arguing that three private-label tooth-whitening strip firms infringed three off its patents for Crest Whitestrips. The defendants plan to appeal the ruling against their motion that two of P&G’s patents are invalid.
You may also be interested in...
In Brief
Bayer buys herbal firm; NBTY notes bright spots, hires international leader; Neptune prepares to rebuild; P&G suit targets CAO’s tooth whiteners; CSPI supports restricting St. John’s wort; Coppertone schools parents; Hillary Clinton will speak at NACDS Total Store Expo.
In Brief
Perrigo divests personal hygiene assets; P&G sues whitening strip private labeler; Purimune contamination prompts Baby Move recall; FDA sounds alarm on Oto-Ease recall; more news In Brief.
Avadim Adamant Its Support For Homeopathic Topical Ad Claims Meets FTC Standards
Avadim Health could get FTC scrutiny after it declines to comply with two findings by an industry self-regulation group to discontinue 26 claims for its Theraworx Relief homeopathic products. It says the analysis “misapplied the well-recognized standards of substantiation” established by FTC.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: